TGFBR1 and pulmonary arterial hypertension: The kinase inhibition of TGF-β receptor 1 (TGFβR1) suppressed the abnormal proliferation of PASMCs and PAECs and improved hemodynamics and vascular remodeling in PAH animal models [11,12,13].